These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39056211)

  • 1. Cost-effectiveness analysis of a digital diabetes-prevention programme versus an in-person diabetes-prevention programme in people with prediabetes in the United States.
    Park S; Ballreich J; Ward T; Shi L
    Diabetes Obes Metab; 2024 Oct; 26(10):4522-4534. PubMed ID: 39056211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review.
    Zhou X; Siegel KR; Ng BP; Jawanda S; Proia KK; Zhang X; Albright AL; Zhang P
    Diabetes Care; 2020 Jul; 43(7):1593-1616. PubMed ID: 33534726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
    Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
    BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
    Eddy DM; Schlessinger L; Kahn R
    Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
    Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE;
    Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
    Palmer AJ; Tucker DM
    Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial.
    Michaud TL; Wilson KE; Katula JA; You W; Estabrooks PA
    Transl Behav Med; 2023 Jul; 13(7):501-510. PubMed ID: 36809348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of a Short Message Service Intervention to Prevent Type 2 Diabetes from Impaired Glucose Tolerance.
    Wong CK; Jiao FF; Siu SC; Fung CS; Fong DY; Wong KW; Yu EY; Lo YY; Lam CL
    J Diabetes Res; 2016; 2016():1219581. PubMed ID: 26798647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost saving analysis of prediabetes intervention modalities in comparison with inaction using Markov state transition model-A multiregional case study.
    Al-Omar HA; Czech M; Quang Nam T; Gottwald-Hostalek U; Vesic N; Whitehouse J; Dawson M
    J Diabetes; 2024 May; 16(5):e13553. PubMed ID: 38664882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2012 Apr; 35(4):723-30. PubMed ID: 22442395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the cost-effectiveness of lifestyle modification versus metformin therapy for the prevention of diabetes in Singapore.
    Png ME; Yoong JS
    PLoS One; 2014; 9(9):e107225. PubMed ID: 25203633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative HbA1c cutoffs to identify high-risk adults for diabetes prevention: a cost-effectiveness perspective.
    Zhuo X; Zhang P; Selvin E; Hoerger TJ; Ackermann RT; Li R; Bullard KM; Gregg EW
    Am J Prev Med; 2012 Apr; 42(4):374-81. PubMed ID: 22424250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial.
    Leal J; Ahrabian D; Davies MJ; Gray LJ; Khunti K; Yates T; Gray AM
    BMJ Open; 2017 Jan; 7(1):e013592. PubMed ID: 28069625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program.
    Vojta D; Koehler TB; Longjohn M; Lever JA; Caputo NF
    Am J Prev Med; 2013 Apr; 44(4 Suppl 4):S301-6. PubMed ID: 23498291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrained.
    Olchanski N; van Klaveren D; Cohen JT; Wong JB; Ruthazer R; Kent DM
    Acta Diabetol; 2021 Jun; 58(6):707-722. PubMed ID: 33517494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2003 Sep; 26(9):2518-23. PubMed ID: 12941712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data.
    Leal J; Reed SD; Patel R; Rivero-Arias O; Li Y; Schulman KA; Califf RM; Holman RR; Gray AM
    Diabetes Care; 2020 Oct; 43(10):2485-2492. PubMed ID: 32796009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program.
    Sathish T; Oldenburg B; Thankappan KR; Absetz P; Shaw JE; Tapp RJ; Zimmet PZ; Balachandran S; Shetty SS; Aziz Z; Mahal A
    BMC Med; 2020 Sep; 18(1):251. PubMed ID: 32883279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis.
    Glechner A; Keuchel L; Affengruber L; Titscher V; Sommer I; Matyas N; Wagner G; Kien C; Klerings I; Gartlehner G
    Prim Care Diabetes; 2018 Oct; 12(5):393-408. PubMed ID: 30076075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achievable cost saving and cost-effective thresholds for diabetes prevention lifestyle interventions in people aged 65 years and older: a single-payer perspective.
    Anderson JM
    J Acad Nutr Diet; 2012 Nov; 112(11):1747-54. PubMed ID: 23102174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.